• Updated

Pfizer reported a dip in profits Tuesday, driven partly by lower sales of Covid-19 therapeutic drug Paxlovid, as it maintained a 2025 forecast that does not include potential tariff effects.

  • Updated

Swiss pharmaceutical giant Roche on Tuesday announced plans to invest $50 billion in the United States over the next five years, following in the footsteps of rival Novartis, with US President Donald Trump's tariff war fuelling uncertainty in the sector.

  • Updated

US President Donald Trump signed an executive order Tuesday aiming to lower crippling drug prices by giving states more leeway to bargain-hunt abroad and improving the process for price negotiations.